CAMP Q3 2017 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$126M

Q3 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$90M-0.8% YoY

Gross Profit

$37M41.0% margin

Operating Income

$3M3.5% margin

Net Income

$12M13.6% margin

EPS (Diluted)

$0.34

QoQ Revenue Growth

+1.9%

Cash Flow

Operating Cash Flow

$25M

Free Cash Flow

$23M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$446M

Total Liabilities

$260M

Stockholders' Equity

$186M

Cash & Equivalents

$127M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$90M	$90M	-0.8%
Gross Profit	$37M	$38M	-2.1%
Operating Income	$3M	$4M	-19.8%
Net Income	$12M	$521,000	+2247.8%

Revenue Segments

Telematics Systems

$74M83%

SoftwareAndSubscriptionServicesMember

$16M17%

Geographic Segments

United States

$66M73%

Europe, Middle East and Africa

$11M13%

Canada

$4M5%

Asia and Pacific Rim

$3M4%

All other

$3M3%

South America

$2M2%